Ozaki, Y., Koide, M., Furuya, Y., Ninomiya, T., Yasuda, H., Nakamura, M., . . . Udagawa, N. (2017). Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis. PLoS One.
Citação norma ChicagoOzaki, Yuki, et al. "Treatment of OPG-deficient Mice With WP9QY, a RANKL-binding Peptide, Recovers Alveolar Bone Loss By Suppressing Osteoclastogenesis and Enhancing Osteoblastogenesis." PLoS One 2017.
MLA citiranjeOzaki, Yuki, et al. "Treatment of OPG-deficient Mice With WP9QY, a RANKL-binding Peptide, Recovers Alveolar Bone Loss By Suppressing Osteoclastogenesis and Enhancing Osteoblastogenesis." PLoS One 2017.
Opozorilo: Ti citati niso vedno 100% točni.